Notification of current cessation of supply of Gallium-67
Today the Working Group received the following information from ANSTO:
We regret to advise, at this point, ANSTO will not be able to supply Gallium-67 in 2021.
The cost of Gallium-67 will increase significantly from 1 January 2021 for ANSTO. Whilst discussions continue, we have not reached an agreement with Lantheus Medical Imaging, the product manufacturer in the USA, nor Global Medical Solutions, the owner of the TGA registration for Gallium-67 in Australia.
ANSTO understands that Gallium-67 will still be available from Global Medical Solutions or its distributors, however, until an agreement is reached, we will not be able to supply the product on and from 1 January 2021.
Customer Service will reach out to customers in the coming weeks. In the meantime, we thank you for your continued support, and if you have any questions, please contact us.